Vascular EDS Research
VEDS Research & Clinical Trials
Elucidating functional significance of ‘Variants of Uncertain Significance’ by generating and characterising a zebrafish model for Vascular Ehlers-Danlos Syndrome.
Dr Meena Balasubramanian, Consultant Clinical Geneticist and Senior Clinical Lecturer, University of Sheffield and Sheffield Children’s NHS Foundation Trust
Developing a lifestyle intervention aiming to support people with vascular Ehlers Danlos Syndrome (vEDS)
Markos Klonizakis, Professor of Vascular and Clinical Physiology
UK adult patients genetically confirmed diagnosed vEDS.
Planned start Feb 2025
This research study is looking at ways to help people affected by vascular Ehlers Danlos Syndrome (vEDS) to talk about the condition in their family.
Claire Green, Genetic Counsellor
UK adult patients genetically confirmed diagnosed vEDS.
Recruitment Closed
Investigating the oral manifestations of Ehlers Danlos Syndrome.
Jim Scott, Restorative Academic Clinic Fellow
UK adult patients genetically confirmed diagnosed vEDS or cEDS.
Recruitment Closed
Diagnosis and Management of Vascular Ehlers-Danlos syndrome: Experience of the UK National Diagnostic Service, Sheffield
EDS Service, Sheffield
Exploring how living with Vascular Ehlers-Danlos Syndrome affects partner relationships and family planning.
Angharad Cullinane, MSc Genetic and Genomic Counselling Student and Trainee Genetic Counsellor
UK adult patients genetically confirmed diagnosed vEDS.
Recruitment closed
The NEEDS study aims to increase knowledge about the clinical and genetic features of children and adults with rare types of EDS by having, amongst other things, a research database.
Dr Fleur van Dijk
UK adult patients genetically confirmed diagnosed rare EDS types.
Ongoing
VEDS Clinical Trial. The trial will study the investigational oral compound, enzastaurin, for its inhibition of the protein kinase C (PKC) pathway.
Aytu BioPharma
Zevra Therapeutics plans to conduct a clinical trial in the U.S. to evaluate the efficacy of a medicine known as celiprolol for the treatment of Vascular Ehlers-Danlos Syndrome (VEDS).
Zevra Therapeutics
Leanne Barrett, Genetic Counsellor
Exploring Vascular Ehlers-Danlos Syndrome Patients’ Perception of Diagnosis, Treatment, and Access to Ongoing Care.
Taylor Speziale, Charlotte Cowan & Kaitlyn Johnston, MSc Genetic and Genomic Counselling students.
Understanding the Utilization of PGT Among Individuals with Inherited Aortic or Vascular Disease.
Kaleigh Patton
Creation of VEDS Research Database at Northwick Park Hospital, London.
Dr Neeti Ghali & Dr Fleur van Dijk, Consultant clinical geneticists.
Natural history study to define the contribution of known VEDS gene mutations to VEDS complications and outcomes.
Dr Sherene Shalhub, Vascular Surgeon.
New Paper Published!
A unique collaborative model providing supportive and self-advocacy tools to the rare disease community.
Juliette M. Harris, Jacqui Fish, Jared Griffin, Gemma Hasnaoui, Clare Stacey, Neeti Ghali, Fleur S. van Dijk.
This is a great example of collaborative work of the EDS Service, a highly specialised service commissioned by NHS England and Annabelle's Challenge Vascular EDS Charity including health care professionals, patients, carers and members of the emergency care project team.
The recommendations from this unique collaborative model include eight specific domains of self-advocacy: increasing knowledge of rare disease, taking care of mental well-being, taking care of physical well-being including routine care, the development of good working relationships between patients and health care professionals, information accessibility, emergency preparedness, taking part in education and outreach, and involvement in research and feedback opportunities.
Highlights
Research Update
VEDS Steering Group
Thank you for contacting us.
We have now added you to our database for updates on the charity, vascular EDS and any research projects.